Document is current
Any future updates will be listed below
-
Authors
Told, Reinhard https://orcid.org/0000-0003-2046-7081
Kreminger, Judith https://orcid.org/0000-0002-1548-3629
Schmidt-Erfurth, Ursula https://orcid.org/0000-0002-7788-7311
Dunavoelgyi, Roman https://orcid.org/0000-0002-1842-240X
Reumueller, Adrian https://orcid.org/0000-0003-4344-4624
- License Information
-
More Information
Article History
Received: 14 June 2023
Accepted: 1 August 2023
First Online: 4 September 2023
Declarations
:
: The authors have no conflict or financial interest to declare regarding this publication. Prof. U. Schmidt-Erfurth is a consultant for Genentech, Kodiak, Novartis, Roche, and RetInSight.
: The Ethics Committee of the Medical University of Vienna, Vienna, Austria, approved the protocol of the present study (EK 1888/2016; ClinicalTrials.gov: NCT05733728), which was conducted in adherence to the Declaration of Helsinki (including current revisions) and the Good Clinical Practice (GCP) guidelines. Written informed consent was not obtained as this study was of a retrospective nature.
